The global veterinary diagnostics market, valued at USD 8.43 billion in 2025, is projected to reach USD 24.15 billion by 2035, growing at a robust CAGR of 11.10%. This growth reflects increasing demand for advanced diagnostic technologies in animal healthcare, driving innovation and investment in the sector.
Veterinary Diagnostics Market Statical Scope
| Reports Attributes |
Statistics |
| Market Size in 2025 |
USD 8.43 Billion |
| Market Size in 2026 |
USD 9.37 Billion |
| Market Size in 2032 |
USD 17.61 Billion |
| Market Size by 2035 |
USD 24.15 Billion |
| CAGR 2026 to 2035 |
11.10% |
| Base Year |
2025 |
| Forecast Period |
2026 to 2035 |
The growth factors leading the market are the expansion of pet insurance and increasing adoption volume among pet lovers. The sheer concentration on preventive healthcare helps pets’ regular health monitoring, with no negligence of their unspoken pain.
The veterinary diagnostics consist of diversified pathways like methods, technologies, and tools for veterinarians to treat animals infected by severe indicators, parasites, or pathogens. The diagnostic procedure involves blood tests, molecular processes, and imaging to spot any unfavorable deficiency in animals and proceed with the prior treatment. The cure for animals starts with the best handling, planning, and suitable infrastructure, which eases the advanced diagnostic process.
The growing disease prevalence and rapid pet humanization strengthen the core market business covering both the local and pet animal population. Adherence to these technological advancements, like point-of-care diagnostics and on-farm tech solutions, helps veterinarians to make quick treatment decisions. The exponential growth of consumable-based tests brings a particular segmental share of profit to the market.
Veterinary Diagnostics Market Share, By Region, 2025 (%)
| Regions |
Shares (%) |
| North America |
41% |
| Europe |
28% |
| Asia-Pacific |
20% |
| Latin America |
6% |
| Middle East & Africa |
5% |
- North America – The North America regional segment dominated the market with the highest of its 41% compatibility with the technological advancements. The massive adoption rate of AI-powered imaging molecular diagnostics has accelerated the market growth in multiple vet spaces.
- Europe – The Europe regional segment is expected to rise by 28% of share with the massive growth in telemedicine, which brings convenient remote consultation in the market frame. The blooming connection between animals and humans features a pet ownership flow, proving effective for regional market growth.
- Asia-Pacific – Asia-Pacific acquires 20% of market share with its commendable diagnostics infrastructure, giving more space for animals’ quality care with robust technologies, potentially prioritizing animals' health.
- Latin America – Latin America held 6% of the market share due to growing livestock productivity. The clear target on zoonotic diseases unveiled the spectacular potential of the regional market, flaunting tech integrations in the vet settings.
- Middle East & Africa – The MEA region is steady yet effective with 5% of market share due to valuable regulatory support, mainly in Saudi Arabia, stating veterinary diagnostics are mandatory to avoid disease transmission. The region is much like an alarm of awareness, contributing to the market.
Veterinary Diagnostics Market Share, By Product, 2025 (%)
| Segments |
Shares (%) |
| Consumables, Reagents & Kits |
53% |
| Equipment & Instruments |
47% |
- Consumables, Reagents & Kits – The consumables, reagents, and kits segment dominated the market with 53%, as it’s a primary (first-line) cooperative solution to proceed with diagnostic procedures, especially in routine testing.
- Equipment & Instruments – The equipment and instruments segment is expected to grow at a share of 47%. The growing advanced imaging, POC, and PCR lead to an exponential rise in testing instruments to align best with advanced treatments.
Veterinary Diagnostics Market Share, By Animal, 2025 (%)
| Segments |
Shares (%) |
| Companion Animals |
62% |
| Production Animals |
38% |
- Companion Animals – The companion animals segment dominated the market with 62% proving percentage, covering the demand for wellness and preventive care, as the animals are the family members for the owners.
- Production Animals – The production animals segment is expected to rise at a share of 38% as producers are simply moving towards diagnostics for metabolic, reproductive, and respiratory conditions, and thereby boosting the livestock productivity.
Veterinary Diagnostics Market Share, By Testing Category, 2025 (%)
| Segments |
Shares (%) |
| Clinical Chemistry |
24% |
| Cytopathology |
6% |
| Microbiology |
10% |
| Hematology |
12% |
- Clinical Chemistry – The clinical chemistry segment dominated the market by 24% due to its advanced health screening option at clinics, and the growing geriatric pet population is gaining more traction in the segmental growth.
- Cytopathology – The cytopathology segment is expected to grow at a rate of 6% with the rapid rise in minimally invasive processes, with the additional power of digital cytology innovation. The digital cytology machines and AI cover the distance with the pathologist by providing quick, brief imaging of slides to the pathologist team.
- Microbiology – The microbiology segment is leading with 10% of market share due to growing awareness of transmitted conditions. The automation in laboratories is stimulating the segmental growth.
- Hematology – The segment rises by 12% with the rising demand for in-clinic testing for better and quicker on-time clinical decisions. The participation of AI to meet precision in CBC results is fuelling automation in the market.
Veterinary Diagnostics Market Share, By End-use, 2025 (%)
| Segments |
Shares (%) |
| Veterinarians |
55% |
| Animal Owners/ Producers |
15% |
| Reference Laboratories |
30% |
- Veterinarians – The veterinarians segment dominated the market with the highest market share of 55% obvious position. The modern in-clinic, molecular diagnostics, and POC are the major strengths of the veterinary pitch.
- Animal Owners/ Producers – The animal owners/producers segment is expected to grow at a share of 15% compelling with the availability of POC testing at the vet clinics. Alongside, the pet insurance policy acts as an encouragement for the segment.
- Reference Laboratories – The segment covers 30% of the market with its potential services to help the vet detect chronic conditions. This leverages sample referrals to advance labs. The growing zoonotic disease is another suitable factor for segmental rise.
